186 related articles for article (PubMed ID: 17573861)
1. Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model.
Kotliar K; Maier M; Bauer S; Feucht N; Lohmann C; Lanzl I
Acta Ophthalmol Scand; 2007 Nov; 85(7):777-81. PubMed ID: 17573861
[TBL] [Abstract][Full Text] [Related]
2. Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide.
Benz MS; Albini TA; Holz ER; Lakhanpal RR; Westfall AC; Iyer MN; Carvounis PE
Ophthalmology; 2006 Jul; 113(7):1174-8. PubMed ID: 16647122
[TBL] [Abstract][Full Text] [Related]
3. [Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection].
Dwinger MC; Pieper-Bodeewes I; Eter N; Holz FG
Klin Monbl Augenheilkd; 2005 Aug; 222(8):638-42. PubMed ID: 16118744
[TBL] [Abstract][Full Text] [Related]
4. Short-term intraocular pressure trends after intravitreal triamcinolone injection.
Lee EW; Hariprasad SM; Mieler WF; Newman TL; Apte RS
Am J Ophthalmol; 2007 Feb; 143(2):365-7. PubMed ID: 17258540
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
[TBL] [Abstract][Full Text] [Related]
6. The effect of selective laser trabeculoplasty on intraocular pressure in patients with intravitreal steroid-induced elevated intraocular pressure.
Rubin B; Taglienti A; Rothman RF; Marcus CH; Serle JB
J Glaucoma; 2008; 17(4):287-92. PubMed ID: 18552614
[TBL] [Abstract][Full Text] [Related]
7. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
[TBL] [Abstract][Full Text] [Related]
8. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
Roth DB; Verma V; Realini T; Prenner JL; Feuer WJ; Fechtner RD
Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
[TBL] [Abstract][Full Text] [Related]
9. Frequency and management of raised intraocular pressure following intravitreal triamcinolone acetonide.
Mahar PS; Memon AS
J Coll Physicians Surg Pak; 2012 Nov; 22(11):699-702. PubMed ID: 23146849
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone acetonide and intraocular pressure.
Smithen LM; Ober MD; Maranan L; Spaide RF
Am J Ophthalmol; 2004 Nov; 138(5):740-3. PubMed ID: 15531307
[TBL] [Abstract][Full Text] [Related]
12. Short-term effect of intravitreal injection of Ranibizumab (Lucentis) on intraocular pressure.
Gismondi M; Salati C; Salvetat ML; Zeppieri M; Brusini P
J Glaucoma; 2009 Dec; 18(9):658-61. PubMed ID: 20010243
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection.
Breusegem C; Vandewalle E; Van Calster J; Stalmans I; Zeyen T
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):573-6. PubMed ID: 18824737
[TBL] [Abstract][Full Text] [Related]
14. Frequency and risk factors for intraocular pressure elevation after posterior sub-Tenon capsule triamcinolone acetonide injection.
Iwao K; Inatani M; Kawaji T; Koga T; Mawatari Y; Tanihara H
J Glaucoma; 2007 Mar; 16(2):251-6. PubMed ID: 17473740
[TBL] [Abstract][Full Text] [Related]
15. Elevation of intraocular pressure after intravitreal injection of triamcinolone acetonide in Taiwanese patients.
Chang YC; Wu WC
Kaohsiung J Med Sci; 2008 Feb; 24(2):72-7. PubMed ID: 18281223
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone.
Shukla D; Vidhya N; Prasad NM; Mahalakshmi R; Kolluru C; Krishnadas R
Am J Ophthalmol; 2007 Sep; 144(3):453-4. PubMed ID: 17765428
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
18. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study.
Inatani M; Iwao K; Kawaji T; Hirano Y; Ogura Y; Hirooka K; Shiraga F; Nakanishi Y; Yamamoto H; Negi A; Shimonagano Y; Sakamoto T; Shima C; Matsumura M; Tanihara H
Am J Ophthalmol; 2008 Apr; 145(4):676-681. PubMed ID: 18243153
[TBL] [Abstract][Full Text] [Related]
19. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
20. Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.
Ruiz-Moreno JM; Montero JA; Amat P; Lugo FL
J Glaucoma; 2009 Jan; 18(1):69-72. PubMed ID: 19142138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
